Doctor Charlotte Van Edom

Doctor Charlotte Van Edom

KU Leuven, Leuven (Belgium)

Member of:

Cardiologist in training and PhD candidate at the University Hospitals of Leuven (Belgium) with a focused interest in haematological complications associated with mechanical circulatory support. She actively contributes to the field as a member of the Young Community and the Antithrombotic Task Force within the Association for Acute Cardiovascular Care of ESC.

Presentations

Dual guided heparin monitoring with anti-Xa and APTT during micro-axial flow pump support for cardiogenic shock

Event: ESC Congress 2024

Topic: Cardiogenic Shock

Session: Advancing the diagnosis and management of patients with cardiac arrest and cardiogenic shock

Access

How to personalise antithrombotic treatment in the patient on mechanical circulatory support

Event: ESC Congress 2024

Topic: Cardiogenic Shock

Session: Personalised management of the patient on mechanical circulatory support in the cardiac care unit

Access

European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: insights from an international survey

Event: ESC Congress 2024

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: The best acute cardiovascular-care science

Access

Anti-Xa/APTT discrepancy in heparinized ImpellaTM-supported cardiogenic shock patients can predict mortality

Event: ESC Acute CardioVascular Care 2024

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Best practices in temporary mechanical circulatory support

Access

European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: an international survey of the ACVC Association of the ESC joint with EuroELSO

Event: ESC Acute CardioVascular Care 2024

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Best practices in temporary mechanical circulatory support

Access

Heparin monitoring in ImpellaTM-supported cardiogenic shock patients: the benefit of parallel dual testing

Event: ESC Acute CardioVascular Care 2024

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Young Investigator Awards

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Charlotte Van Edom

Biography

Contributor content

Dual guided heparin monitoring with anti-Xa and APTT during micro-axial flow pump support for cardiogenic shock

How to personalise antithrombotic treatment in the patient on mechanical circulatory support

European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: insights from an international survey

Anti-Xa/APTT discrepancy in heparinized ImpellaTM-supported cardiogenic shock patients can predict mortality

European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: an international survey of the ACVC Association of the ESC joint with EuroELSO

Heparin monitoring in ImpellaTM-supported cardiogenic shock patients: the benefit of parallel dual testing

ESC 365 is supported by

Doctor Charlotte Van Edom Follow

Biography

Contributor content

Dual guided heparin monitoring with anti-Xa and APTT during micro-axial flow pump support for cardiogenic shock

How to personalise antithrombotic treatment in the patient on mechanical circulatory support

European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: insights from an international survey

Anti-Xa/APTT discrepancy in heparinized ImpellaTM-supported cardiogenic shock patients can predict mortality

European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: an international survey of the ACVC Association of the ESC joint with EuroELSO

Heparin monitoring in ImpellaTM-supported cardiogenic shock patients: the benefit of parallel dual testing

ESC 365 is supported by

Doctor Charlotte Van Edom